Oxidative stress and endothelial function: therapeutic interventions.

Area of Science:

• Vascular Biology
• Oxidative Stress Research
• Cardiovascular Disease Pathophysiology

Background:

• Cardiovascular risk factors like hypertension and diabetes elevate reactive oxygen species (ROS) production in the vascular wall.
• Oxidative stress and endothelial dysfunction are key factors in coronary and peripheral circulation, impacting cardiovascular event prognosis.
• Enzyme systems, including NADPH oxidase and uncoupled eNOS, contribute to ROS generation, while decreased nitric oxide (NO) bioavailability impairs vascular relaxation.

Purpose of the Study:

• To review the role of oxidative stress and endothelial dysfunction in vascular diseases.
• To examine the impact of various oxidase enzymes on reactive oxygen species (ROS) production.
• To discuss the clinical trial evidence for antioxidants, antihypertensives, and hypolipidemic medications in managing vascular health.

Main Methods:

• Literature review of studies on oxidative stress, endothelial function, and cardiovascular risk factors.
• Analysis of enzyme systems involved in ROS production and NO metabolism.
• Evaluation of clinical trial data for antioxidant interventions, vitamins C and E, and pharmaceutical agents.

Main Results:

• Reactive oxygen species (ROS) are generated by multiple enzymes, contributing to endothelial dysfunction and reduced nitric oxide (NO) bioavailability.
• Small studies suggest potential benefits of vitamins C and E for endothelial function in high-risk patients.
• Larger trials on antioxidants have yielded controversial results, with some indicating potential harm in specific populations.

Conclusions:

• Antihypertensive and hypolipidemic medications demonstrate antioxidant effects and improve endothelial function.
• Further investigation into novel antioxidant strategies and recent patents is necessary to fully elucidate their therapeutic potential in vascular diseases.